Treatment of Renal Sarcoidosis by Methylprednisolone Bolus
Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Renal sarcoidosis treatment is based on steroids, but the dose and duration are unknown.
Despite this treatment, most patients will have chronic kidney disease. From our previous
studies, the investigators believe that high dose steroids by methylprednisolone bolus will
improve patient outcome and renal function.